← Leaderboards
John Tisdale
National Heart, Lung, And Blood Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Heart, Lung, And Blood Institute
Same institution · by research overlap
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsTransplantationSourceGlobinClinical ApplicationEngraftmentGene TransferGenesSickle Cell AnemiaClinical TrialsBaseAnimal ModelIrradiationDoseStem CellsHematopoieticPeripheral Blood Stem CellMarrowPeripheral BloodBone Marrow TransplantationProductionConditioningHemoglobinopathiesThalassemia
Grant awards (53)
Nonmyeloablative allogeneic PBSC in globin disorders$1,943,482
ZIA · FY2025 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$1,457,612
ZIA · FY2025 · HL · contact PI
Preclinical and Clinical Studies in Gene Therapy for Sickle Cell Disease$1,457,612
ZIA · FY2025 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,999,033
ZIA · FY2024 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$1,499,275
ZIA · FY2024 · HL · contact PI
Preclinical and Clinical Studies in Gene Therapy for Sickle Cell Disease$1,499,275
ZIA · FY2024 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,792,190
ZIA · FY2023 · HL · contact PI
Preclinical and Clinical Studies in Gene Therapy for Sickle Cell Disease$1,344,142
ZIA · FY2023 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$1,344,142
ZIA · FY2023 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,541,591
ZIA · FY2022 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$1,143,047
ZIA · FY2022 · HL · contact PI
A preclinical large animal model for globin gene transfer$1,143,047
ZIA · FY2022 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,549,431
ZIA · FY2021 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$1,162,073
ZIA · FY2021 · HL · contact PI
A preclinical large animal model for globin gene transfer$1,162,073
ZIA · FY2021 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,443,650
ZIA · FY2020 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$1,080,591
ZIA · FY2020 · HL · contact PI
A preclinical large animal model for globin gene transfer$1,050,591
ZIA · FY2020 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,034,672
ZIA · FY2019 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$845,339
ZIA · FY2019 · HL · contact PI
A preclinical large animal model for globin gene transfer$838,713
ZIA · FY2019 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$495,926
ZIA · FY2018 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$481,339
ZIA · FY2018 · HL · contact PI
A preclinical large animal model for globin gene transfer$481,339
ZIA · FY2018 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$593,389
ZIA · FY2017 · HL · contact PI
A preclinical large animal model for globin gene transfer$575,937
ZIA · FY2017 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$575,937
ZIA · FY2017 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$588,067
ZIA · FY2016 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$570,763
ZIA · FY2016 · HL · contact PI
A preclinical large animal model for globin gene transfer$570,763
ZIA · FY2016 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$564,084
ZIA · FY2015 · HL · contact PI
A preclinical large animal model for globin gene transfer$547,494
ZIA · FY2015 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$547,494
ZIA · FY2015 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$533,453
ZIA · FY2014 · HL · contact PI
A preclinical large animal model for globin gene transfer$517,763
ZIA · FY2014 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$517,763
ZIA · FY2014 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,322,542
ZIA · FY2012 · HL · contact PI
A preclinical large animal model for globin gene transfer$1,021,276
ZIA · FY2012 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$585,955
ZIA · FY2012 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,378,152
ZIA · FY2011 · HL · contact PI
A preclinical large animal model for globin gene transfer$1,074,178
ZIA · FY2011 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$613,083
ZIA · FY2011 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$1,194,259
ZIA · FY2010 · HL · contact PI
A preclinical large animal model for globin gene transfer$911,646
ZIA · FY2010 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$700,664
ZIA · FY2010 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$480,096
ZIA · FY2009 · HL · contact PI
A preclinical large animal model for globin gene transfer$411,511
ZIA · FY2009 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$274,341
ZIA · FY2009 · HL · contact PI
Development of improved lentiviral vectors for human gene therapy applications$205,756
ZIA · FY2009 · HL · contact PI
Nonmyeloablative allogeneic PBSC in globin disorders$384,475
Z01 · FY2008 · HL · contact PI
A preclinical large animal model for globin gene transfer$329,550
Z01 · FY2008 · HL · contact PI
Isolation, characterization, and transplantation of candidate stem cells$219,700
Z01 · FY2008 · HL · contact PI
Development of improved lentiviral vectors for human gene therapy applications$164,775
Z01 · FY2008 · HL · contact PI